Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients

BACKGROUND AND OBJECTIVES: The identification of predictors of response to antiCGRP mAbs could favor tailored therapies and personalized treatment plans. This study is aimed at investigating predictors of ≥ 50%, ≥ 75% and 100% response at 24 weeks in patients with high-frequency episodic (HFEM: 8–14...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbanti, Piero, Egeo, Gabriella, Aurilia, Cinzia, Altamura, Claudia, d’Onofrio, Florindo, Finocchi, Cinzia, Albanese, Maria, Aguggia, Marco, Rao, Renata, Zucco, Maurizio, Frediani, Fabio, Filippi, Massimo, Messina, Roberta, Cevoli, Sabina, Carnevale, Antonio, Fiorentini, Giulia, Messina, Stefano, Bono, Francesco, Torelli, Paola, Proietti, Stefania, Bonassi, Stefano, Vernieri, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623966/
https://www.ncbi.nlm.nih.gov/pubmed/36316648
http://dx.doi.org/10.1186/s10194-022-01498-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623966/
https://www.ncbi.nlm.nih.gov/pubmed/36316648
http://dx.doi.org/10.1186/s10194-022-01498-6

Ejemplares similares